Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment
Nexalin Technology, Inc. (NXL)
Company Research
Source: GlobeNewswire
HOUSTON, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announced its participation in a high-profile Congressional roundtable in North Carolina, focused on emerging virtual therapeutic options for opioid treatment. The event was hosted by the Breaking Barriers for Substance Use Recovery initiative and featured key stakeholders from across the healthcare and policy spectrum. The roundtable, held with Dr. Greg Murphy, U.S. Congressman representing North Carolina's 3rd District, centered on the deployment of virtual-based opioid therapy models across the country. Dr. Murphy, Congress’ only actively practicing physician, serves on the Health Subcommittee of the Veterans Affairs Committee and is a strong advocate for innovative healthcare solutions, particularly those aimed at addressing the opioid crisis. The invitation-only roundtable brought together thought leaders and innovators to discuss the potential
Show less
Read more
Impact Snapshot
Event Time:
NXL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NXL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NXL alerts
High impacting Nexalin Technology, Inc. news events
Weekly update
A roundup of the hottest topics
NXL
News
- Nexalin Technology CEO Provides Letter to ShareholdersGlobeNewswire
- Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? [Yahoo! Finance]Yahoo! Finance
- Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5thGlobeNewswire
- Nexalin Technology Regains Compliance with Nasdaq Continued Listing RequirementsGlobeNewswire
- Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's DiseaseGlobeNewswire
NXL
Sec Filings
- 11/8/24 - Form 10-Q
- 11/1/24 - Form 8-K
- 10/30/24 - Form 4
- NXL's page on the SEC website